Literature DB >> 17130631

Perceptions of industry responsibility and tobacco control policy by US tobacco company executives in trial testimony.

Michael Chaiton1, Roberta Ferrence, Eric LeGresley.   

Abstract

OBJECTIVE: Trial testimony from the United States provides a unique opportunity to examine strategies of the American tobacco industry. This paper examines congruence between the arguments for tobacco control policy presented by representatives of the American tobacco industry at trial and the stages of responsibility associated with corporate social responsibility principles in other industries. DATA SOURCES: Trial testimony collected and coded by the Deposition and Trial Testimony Archive (DATTA). STUDY SELECTION: All available testimony was gathered from representative senior staff from major tobacco companies: Brown & Williamson, Philip Morris, RJ Reynolds, and Liggett. DATA EXTRACTION: Transcripts from each witness selected were collected and imported in text format into WinMax, a qualitative data program. The documents were searched for terms relating to tobacco control policies, and relevant terms were extracted. A hand search of the documents was also conducted by reading through the testimony. Inferred responsibility for various tobacco control policies (health information, second-hand smoking, youth smoking) was coded. DATA SYNTHESIS: The level of responsibility for tobacco control policy varied according to the maturity of the issue. For emerging issues, US tobacco company representatives expressed defensiveness while, for more mature issues, such as youth smoking, they showed increased willingness to deal with the issue. This response to social issues is consistent with corporate social responsibility strategies in other industries.
CONCLUSION: While other industries use corporate social responsibility programmes to address social issues to protect their core business product, the fundamental social issue with tobacco is the product itself. As such, the corporate nature of tobacco companies is a structural obstacle to reducing harm caused by tobacco use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130631      PMCID: PMC2563591          DOI: 10.1136/tc.2004.009647

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  17 in total

Review 1.  Thinking the "unthinkable": why Philip Morris considered quitting.

Authors:  E A Smith; R E Malone
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

Review 2.  Legal strategies to reduce tobacco-caused disease.

Authors:  David Sweanor
Journal:  Respirology       Date:  2003-12       Impact factor: 6.424

3.  Clean indoor air: where, why, and how.

Authors:  Rosemarie Henson; Larry Medina; Steve St Clair; Doug Blanke; Larry Downs; Jerelyn Jordan
Journal:  J Law Med Ethics       Date:  2002       Impact factor: 1.718

4.  Advocacy in action: extreme corporate makeover interruptus: denormalising tobacco industry corporate schmoozing.

Authors:  S Chapman
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

5.  Dealing with tobacco--the implications of a legislative settlement with the tobacco industry.

Authors:  K E Warner
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

6.  Preemption in tobacco control. Review of an emerging public health problem.

Authors:  M Siegel; J Carol; J Jordan; R Hobart; S Schoenmarklin; F DuMelle; P Fisher
Journal:  JAMA       Date:  1997-09-10       Impact factor: 56.272

Review 7.  "If we can just 'stall' new unfriendly legislations, the scoreboard is already in our favour": transnational tobacco companies and ingredients disclosure in Thailand.

Authors:  R MacKenzie; J Collin; K Sriwongcharoen; M E Muggli
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

8.  Corporate social responsibility and the tobacco industry: hope or hype?

Authors:  N Hirschhorn
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

Review 9.  Breaking and re-entering: British American Tobacco in China 1979-2000.

Authors:  K Lee; A B Gilmore; J Collin
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

10.  A strategy for controlling the marketing of tobacco products: a regulated market model.

Authors:  R Borland
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

View more
  5 in total

1.  Do we believe the tobacco industry lied to us? Association with smoking behavior in a military population.

Authors:  Robert C Klesges; Deborah A Sherrill-Mittleman; Margaret Debon; G Wayne Talcott; Robert J Vanecek
Journal:  Health Educ Res       Date:  2009-06-15

2.  Social responsibility in tobacco production? Tobacco companies' use of green supply chains to obscure the real costs of tobacco farming.

Authors:  Marty Otañez; Stanton A Glantz
Journal:  Tob Control       Date:  2011-04-19       Impact factor: 7.552

3.  Success counteracting tobacco company interference in Thailand: an example of FCTC implementation for low- and middle-income countries.

Authors:  Naowarut Charoenca; Jeremiah Mock; Nipapun Kungskulniti; Sunida Preechawong; Nicholas Kojetin; Stephen L Hamann
Journal:  Int J Environ Res Public Health       Date:  2012-03-27       Impact factor: 3.390

4.  Big tobacco focuses on the facts to hide the truth: an algorithmic exploration of courtroom tropes and taboos.

Authors:  Stephan Risi; Robert N Proctor
Journal:  Tob Control       Date:  2019-09-13       Impact factor: 7.552

5.  Stakeholders' opinions about a tobacco policy in Lao PDR.

Authors:  Tanja Tomson; Kongsap Akkhavong; Hans Gilljam
Journal:  Tob Induc Dis       Date:  2009-01-14       Impact factor: 2.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.